Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin

被引:268
|
作者
Cavalli, R [1 ]
Gasco, MR
Chetoni, P
Burgalassi, S
Saettone, MF
机构
[1] Univ Turin, Dipartimento Sci & Tecnol & Farm, I-10125 Turin, Italy
[2] Univ Pisa, Dipartimento Chim Bioorgan & Biofarm, I-56126 Pisa, Italy
关键词
solid lipid nanoparticles; SLN; tobramycin; rabbits; preocular retention; ocular delivery; aqueous humour bioavailability;
D O I
10.1016/S0378-5173(02)00080-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim of this study was to evaluate solid lipid nanoparticles (SLN) as carriers for topical ocular delivery of tobramycin JOB). The SLN were in the colloidal size range (average diameter below 100 nm; polydispersity index below 0.2) and contained 2.5% TOB as ion-pair complex with hexadecyl phosphate. The preocular retention of SLN in rabbit eyes was tested using drug-free, fluorescent SLN (F-SLN): these were retained for longer times on the corneal surface and in the conjunctival sac when compared with an aqueous fluorescent solution. A suspension of TOB-loaded SLN (TOB-SLN) containing 0.3% w/v TOB was administered topically to rabbits, and the aqueous humour concentration of TOB was determined up to six hours. When compared with an equal dose of TOB administered by standard commercial eyedrops, TOB-SLN produced a significantly higher TOB bioavailability in the aqueous humour. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 50 条
  • [31] SOLID LIPID NANOPARTICLES: AN ADVANCED DRUG DELIVERY SYSTEM
    Reddy, Raghu Nandan
    Shariff, Arshia
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (01): : 161 - 171
  • [32] SOLID LIPID NANOPARTICLES: A PROMISING DRUG DELIVERY SYSTEM
    Raut, Indrayani D.
    Doijad, Rajendra C.
    Mohite, Shrinivas K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2018, 9 (03): : 862 - 871
  • [33] Ocular Drug Delivery System-based on Solid Nanoparticles
    Nagai, Noriaki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2021, 141 (01): : 47 - 53
  • [34] SOLID LIPID NANOPARTICLES (SLN) FOR CONTROLLED DRUG-DELIVERY .1. PRODUCTION, CHARACTERIZATION AND STERILIZATION
    SCHWARZ, C
    MEHNERT, W
    LUCKS, JS
    MULLER, RH
    JOURNAL OF CONTROLLED RELEASE, 1994, 30 (01) : 83 - 96
  • [35] Intracellular delivery of 10-hydroxycamptothecin with novel solid lipid nanoparticles (SLN) against multidrug resistance
    Chen, Didi
    Chen, Sha
    Wang, Qing
    Guo, Pei
    Cao, Yu
    Li, Dapeng
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) : E27 - E27
  • [36] Scaling up feasibility of the production of solid lipid nanoparticles (SLN™)
    Gohla, SH
    Dingler, A
    PHARMAZIE, 2001, 56 (01): : 61 - 63
  • [37] Solid lipid nanoparticles (SLN) -: a novel carrier for UV blockers
    Wissing, SA
    Müller, RH
    PHARMAZIE, 2001, 56 (10): : 783 - 786
  • [38] Chemiluminescent Solid Lipid Nanoparticles (SLN) and Interactions with Intact Skin
    Breidenich, Jennifer
    Patrone, Julia
    Kelly, Lisa
    Benkoski, Jason
    Le, Huong
    Sample, Jennifer
    BIOSENSING II, 2009, 7397
  • [39] Solid lipid nanoparticles (SLN) templating of macroporous silica beads
    Pasc, Andreea
    Blin, Jean-Luc
    Stebe, Marie-Jose
    Ghanbaja, Jaafar
    RSC ADVANCES, 2011, 1 (07) : 1204 - 1206
  • [40] Production of solid lipid nanoparticles (SLN): scaling up feasibilities
    Dingler, A
    Gohla, S
    JOURNAL OF MICROENCAPSULATION, 2002, 19 (01) : 11 - 16